Catalyst Pharmaceuticals Inc Capital Reinvestment Ratio
Catalyst Pharmaceuticals Inc capital reinvestment ratio. Catalyst Pharmaceuticals Inc (CPRX) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($59.59 Million) in capital expenditures ($27.00K). Check CPRX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Catalyst Pharmaceuticals Inc (2019–2025)
Capital reinvestment ratio of Catalyst Pharmaceuticals Inc from 2019 to 2025. This chart tracks Catalyst Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore CPRX net asset momentum to track the company's year-over-year net asset growth rate.
Catalyst Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2019–2025)
Catalyst Pharmaceuticals Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $208.67 Million | $58.00K | ▼ -88.0% |
| 2024 | 0.00x | $239.81 Million | $556.00K | ▼ -99.6% |
| 2023 | 0.57x | $143.60 Million | $81.74 Million | ▲ +227691.4% |
| 2022 | 0.00x | $116.05 Million | $29.00K | ▼ -98.5% |
| 2021 | 0.02x | $60.37 Million | $1.02 Million | ▲ +6584.4% |
| 2020 | 0.00x | $45.03 Million | $11.39K | ▼ -54.8% |
| 2019 | 0.00x | $34.61 Million | $19.37K | — |